Does hyperthyroidism cause erectile dysfunction? Evidence suggests a genuine association between these conditions. Hyperthyroidism—excessive thyroid hormone production—affects approximately 1 in 100 people in the UK and can disrupt sexual function in men through hormonal imbalances, vascular changes, and psychological factors. Men with untreated hyperthyroidism may experience erectile dysfunction at higher rates than the general population. Importantly, this represents a potentially reversible cause of ED: normalising thyroid hormone levels through appropriate treatment often leads to substantial improvement in erectile function. Understanding this connection is clinically valuable, as thyroid screening should form part of comprehensive assessment for men presenting with sexual dysfunction.

Understanding Hyperthyroidism and Erectile Dysfunction

Hyperthyroidism is a condition characterised by excessive production of thyroid hormones by the thyroid gland, leading to an accelerated metabolic state. Common causes include Graves' disease, toxic multinodular goitre, and thyroid adenomas. Patients typically present with symptoms such as weight loss, heat intolerance, tremor, palpitations, and anxiety. According to the NHS, an overactive thyroid affects about 1 in 100 people in the UK, with Graves' disease being more common in women than men. Sexual dysfunction in men with hyperthyroidism often remains underdiagnosed.

Erectile dysfunction (ED) is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It is a common condition that becomes increasingly prevalent with age. ED can result from vascular, neurological, hormonal, psychological, or medication-related causes. The condition significantly impacts quality of life, relationships, and psychological wellbeing.

Whilst the link between thyroid disorders and sexual function is less widely recognised than other complications, evidence suggests a genuine association between hyperthyroidism and erectile dysfunction. Research indicates that men with untreated hyperthyroidism may experience ED at higher rates than the general population, though prevalence estimates vary between studies depending on the populations examined. The relationship appears to be multifactorial, involving hormonal imbalances, vascular changes, and psychological factors.

Understanding this connection is clinically important because thyroid dysfunction represents a potentially reversible contributor to ED. Unlike some age-related or vascular causes of ED, which may require long-term management, erectile function often improves substantially once thyroid hormone levels are normalised through appropriate treatment. This makes thyroid screening a valuable consideration in the comprehensive assessment of men presenting with sexual dysfunction.

How Hyperthyroidism Affects Sexual Function in Men

The mechanisms linking hyperthyroidism to erectile dysfunction are complex and multifactorial, involving hormonal, vascular, and psychological pathways. Understanding these mechanisms helps explain why normalising thyroid function often improves sexual health.

Hormonal disruption represents a primary mechanism. Excess thyroid hormones increase the hepatic production of sex hormone-binding globulin (SHBG), which binds testosterone in the bloodstream. This reduces the amount of free, biologically active testosterone available to tissues. Additionally, hyperthyroidism accelerates the peripheral conversion of androgens to oestrogens, further disturbing the hormonal balance. Men with hyperthyroidism frequently demonstrate elevated total testosterone levels but reduced free testosterone, alongside increased oestradiol concentrations. This hormonal profile can impair libido and erectile function.

Cardiovascular effects also contribute. Hyperthyroidism increases cardiac output, heart rate, and systolic blood pressure whilst reducing peripheral vascular resistance. These haemodynamic changes can affect penile blood flow. The condition may also promote endothelial dysfunction—impairment of the blood vessel lining—which is crucial for the vasodilation required for erections.

Psychological factors cannot be overlooked. The anxiety, irritability, and mood disturbances characteristic of hyperthyroidism can directly impact sexual desire and performance. Performance anxiety may develop, creating a cycle that perpetuates erectile difficulties even when physiological factors improve.

Premature ejaculation is another sexual dysfunction reported in some hyperthyroid men. The hyperadrenergic state—excessive sympathetic nervous system activity—associated with thyroid hormone excess may contribute to reduced ejaculatory control. Importantly, these sexual dysfunctions often improve following successful treatment of the underlying hyperthyroidism, supporting a causal relationship, though individual responses vary.

Diagnosing Thyroid-Related Erectile Dysfunction

Comprehensive assessment is essential when evaluating erectile dysfunction potentially related to thyroid disease. NICE guidance on the assessment of ED emphasises the importance of identifying underlying medical conditions, including endocrine disorders.

The diagnostic process begins with a detailed clinical history. Clinicians should enquire about the onset, duration, and severity of erectile difficulties, alongside symptoms suggestive of hyperthyroidism such as:

• Unintentional weight loss despite normal or increased appetite

• Heat intolerance and excessive sweating

• Tremor, particularly of the hands

• Palpitations or irregular heartbeat

• Anxiety, irritability, or sleep disturbance

• Muscle weakness

• Changes in bowel habit (increased frequency)

Validated questionnaires such as the International Index of Erectile Function (IIEF-5) may be used to assess the severity of ED.

Physical examination should include assessment of the thyroid gland for enlargement or nodules, cardiovascular examination (noting tachycardia, atrial fibrillation, or systolic hypertension), and examination for signs such as lid lag, tremor, or proximal muscle weakness. Assessment of secondary sexual characteristics and genital examination may identify other contributory factors.

Laboratory investigations form the cornerstone of diagnosis. In line with NICE guidance, initial thyroid function testing should include:

• Thyroid-stimulating hormone (TSH): typically suppressed in hyperthyroidism

• Free thyroxine (FT4): measured if TSH is abnormal; elevated in hyperthyroidism

• Free triiodothyronine (FT3): measured selectively when TSH is suppressed but FT4 is normal, or to assess T3-toxicosis

For men with confirmed hyperthyroidism and ED, additional hormonal assessment may include:

• Total testosterone: measured in the morning (before 11am) on two separate occasions if initial result is borderline or low

• Sex hormone-binding globulin (SHBG): to calculate free testosterone if total testosterone is borderline or SHBG is likely to be altered

• Luteinising hormone (LH) and follicle-stimulating hormone (FSH): measured if testosterone is low, to evaluate pituitary-gonadal function

• Prolactin: measured if indicated by clinical features or low testosterone

Further investigations depend on clinical findings but may include thyroid antibodies (particularly thyroid-stimulating immunoglobulins for Graves' disease), thyroid ultrasound, or radioisotope scanning. Cardiovascular risk assessment is important, as ED can be an early marker of cardiovascular disease; this should include lipid profile and glucose testing. The presence of ED does not change the standard thyroid work-up; referral to endocrinology should be considered if there is diagnostic uncertainty or features suggesting pituitary disease.

Treatment Options for Hyperthyroidism and ED

Treatment of the underlying hyperthyroidism represents the primary therapeutic approach, as normalising thyroid hormone levels frequently improves erectile dysfunction. The choice of hyperthyroidism treatment depends on the underlying cause, patient age, severity, and individual circumstances, in line with NICE guidance.

Antithyroid medications such as carbimazole (first-line in the UK) or propylthiouracil work by inhibiting thyroid hormone synthesis. Carbimazole is typically initiated at 20–40 mg daily, with dose titration based on thyroid function monitoring. Treatment duration varies but commonly continues for 12–18 months. Important safety information: carbimazole can cause agranulocytosis (a serious reduction in white blood cells). Patients should be advised to stop the medication immediately and seek urgent medical advice if they develop fever, sore throat, mouth ulcers, or signs of infection, so that a full blood count can be checked. Propylthiouracil carries a risk of serious liver toxicity and is generally reserved for specific situations such as the first trimester of pregnancy or thyroid storm. The 'block and replace' regimen—using higher-dose antithyroid medication alongside levothyroxine replacement—may be considered in selected cases but is not routine first-line therapy. Most men experience improvement in erectile function within a few months of achieving euthyroidism (normal thyroid status), though the timeframe and degree of improvement vary between individuals.

Radioiodine therapy offers definitive treatment, particularly for Graves' disease or toxic nodular goitre. Radioactive iodine-131 is administered orally and selectively destroys overactive thyroid tissue. This treatment is contraindicated in pregnancy and breastfeeding, and patients must follow radiation-safety advice regarding contact with others, particularly children and pregnant women. Radioiodine may worsen Graves' orbitopathy (eye disease) in susceptible individuals. Whilst highly effective, this treatment commonly results in hypothyroidism requiring lifelong levothyroxine replacement. Sexual function typically improves once stable euthyroidism is achieved with replacement therapy.

Thyroid surgery (total or subtotal thyroidectomy) may be indicated for large goitres, suspected malignancy, or patient preference. As with radioiodine, subsequent hypothyroidism requires thyroid hormone replacement.

Symptomatic management during the treatment phase may include beta-blockers (such as propranolol) to control cardiovascular symptoms and tremor. These medications do not directly treat hyperthyroidism but improve quality of life whilst awaiting thyroid hormone normalisation.

Specific ED treatment may be considered if erectile dysfunction persists despite achieving euthyroidism. Phosphodiesterase-5 (PDE5) inhibitors—including sildenafil, tadalafil, and vardenafil—represent first-line pharmacological therapy for ED. These medications enhance the natural erectile response by promoting smooth muscle relaxation and increased blood flow to the penis. Important contraindications: PDE5 inhibitors must not be used with nitrates (including glyceryl trinitrate), nicorandil, or riociguat due to the risk of severe hypotension. They should be used with caution in men taking alpha-blockers, those with hypotension, and those with recent myocardial infarction or stroke. Cardiovascular assessment is recommended before prescribing PDE5 inhibitors, particularly in men with cardiovascular complications of hyperthyroidism such as uncontrolled atrial fibrillation or heart failure.

Psychological support and psychosexual counselling benefit some men, particularly when anxiety or relationship difficulties have developed secondary to sexual dysfunction. Lifestyle modifications—including smoking cessation, alcohol moderation, regular exercise, and weight management—support both thyroid and sexual health. Importantly, clinicians should review all medications, as some antihypertensives and antidepressants can contribute to ED.

Reporting side effects: If you experience a suspected side effect from any medication, you can report it via the MHRA Yellow Card Scheme at www.mhra.gov.uk/yellowcard or by searching for 'Yellow Card' in the Google Play or Apple App Store.

When to Seek Medical Advice

Prompt medical consultation is important when experiencing symptoms of either hyperthyroidism or erectile dysfunction, as early diagnosis and treatment optimise outcomes and prevent complications.

Men should contact their GP if they experience:

• Persistent erectile dysfunction: difficulty achieving or maintaining erections on most occasions over a period of several weeks

• Symptoms suggestive of hyperthyroidism: unexplained weight loss, persistent rapid heartbeat, tremor, heat intolerance, or anxiety

• Combined symptoms: the presence of both sexual dysfunction and features of thyroid overactivity

• Impact on quality of life: when sexual difficulties affect relationships, self-esteem, or psychological wellbeing

Emergency medical attention (call 999 or go to A&E) is warranted for:

• Severe chest pain or severe breathlessness

• Thyroid storm symptoms: extreme agitation, fever, very rapid heart rate, and confusion (this is a rare but life-threatening emergency)

Urgent same-day medical advice (contact your GP or call NHS 111) is needed for:

• Severe palpitations with dizziness or feeling faint

• Acute confusion or significant behavioural changes

• Severe muscle weakness affecting mobility

• If taking carbimazole or propylthiouracil: fever, sore throat, mouth ulcers, or signs of infection—stop the medication immediately and seek urgent medical advice for a blood count check

What to expect during consultation: Your GP will take a comprehensive medical history, perform relevant examinations, and arrange blood tests to assess thyroid function and other potential causes of ED. Be prepared to discuss:

• The duration and pattern of erectile difficulties

• Any other symptoms you've noticed

• Current medications and supplements

• Lifestyle factors including smoking, alcohol consumption, and exercise

• Psychological stressors or relationship concerns

Referral pathways may include endocrinology services for complex thyroid disease management, urology for persistent ED unresponsive to initial treatment, or cardiology if cardiovascular complications are present. Do not delay seeking help due to embarrassment—both hyperthyroidism and erectile dysfunction are common medical conditions with effective treatments available. Early intervention prevents disease progression and improves the likelihood of recovery of sexual function.

Men already diagnosed with hyperthyroidism should inform their healthcare team if they develop erectile dysfunction, as this may indicate suboptimal thyroid control or warrant additional assessment. Regular monitoring of thyroid function during treatment ensures optimal hormone levels are maintained, supporting restoration of normal sexual health.

Frequently Asked Questions